MEDNAX, Inc. (MD)
| Market Cap | 2.09B |
| Revenue (ttm) | 1.73B |
| Net Income (ttm) | -796.49M |
| Shares Out | 83.40M |
| EPS (ttm) | -9.55 |
| PE Ratio | n/a |
| Forward PE | 15.70 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | February 26 |
| Last Price | $24.43 |
| Previous Close | $23.97 |
| Change ($) | 0.46 |
| Change (%) | 1.92% |
| Day's Open | 23.87 |
| Day's Range | 23.81 - 24.89 |
| Day's Volume | 936,534 |
| 52-Week Range | 7.37 - 29.26 |
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax to Present at Upcoming Investor Conferences
MEDNAX's (MD) fourth-quarter results reflect muted revenues caused by the COVID-19 pandemic.
Mednax (MD) delivered earnings and revenue surprises of -19.35% and -8.64%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Mednax (NYSE:MD) fell 0.2% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 72.53% year over year to $0.25, which missed th...
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax Reports Fourth Quarter Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax 2020 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 18, 2021
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- #neoconference2021--The virtual NEO conference will continue its longstanding tradition of addressing key areas of neonatal management to improve newbo...
OKLAHOMA CITY--(BUSINESS WIRE)-- #FedermanSherwood--Federman & Sherwood Files First Data Breach Case Against MedNax, Inc. and Pediatrix Medical Group, a MedNax Company
Riding high on its strategic efforts and cost-cutting measures, MEDNAX (MD) holds enough potential to reap benefits for investors.
EL SEGUNDO, Calif.--(BUSINESS WIRE)-- #PracticeNotCompany--Radiology Partners (RP), the leading radiology practice in the U.S., today announced the completion of its acquisition of MEDNAX Radi...
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--MEDNAX Completes Sale of MEDNAX Radiology Solutions to Radiology Partners
Mednax (MD) reported earnings 30 days ago. What's next for the stock?
MEDNAX's (MD) third-quarter results reflect muted revenues and high costs, partly offset by lower interest expense.
MEDNAX, Inc. (MD) CEO Mark Ordan on Q3 2020 Results - Earnings Call Transcript
Shares of Mednax (NYSE:MD) rose 5.3% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share fell 59.34% year over year to $0.37, which missed the est...
Mednax (MD) delivered earnings and revenue surprises of -7.50% and -13.87%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--MEDNAX Reports Third Quarter Results
Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX 2020 Third Quarter Conference Call/Webcast Scheduled for Friday, November 6, 2020
Why this health care strategist likes the work-from-home trade
CNBC's Kelly Evans discusses the best work-from-home health care equity investments with Jared Holz of Jefferies Health Care Strategy.
Riding on restructuring as well as cost-cutting initiatives, MEDNAX (MD) holds potential to reap benefits for investors.
NEW YORK, Sept. 15, 2020 /PRNewswire/ -- DLA Piper represented MEDNAX, Inc.
MEDNAX (MD) reaches an agreement with Radiology Partners to sell its MEDNAX Radiology Solutions, which will lower its debt load and restructure its business.
MEDNAX (MD) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Mednax Inc. MD, +0.73% said Thursday it has reached an agreement to sell its radiology business to physician-owned Radiology Partners for $885 million in cash.
EL SEGUNDO, Calif.--(BUSINESS WIRE)--Radiology Partners (RP), the leading radiology practice in the U.S.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX Announces Agreement to Sell MEDNAX Radiology Solutions to Radiology Partners
Mednax (MD) reported earnings 30 days ago. What's next for the stock?
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX Announces Financial Leadership Transition - C.
MEDNAX, Inc. (MD) CEO Mark Ordan on Q2 2020 Results - Earnings Call Transcript
MEDNAX's (MD) Q2 results reflect lower expenses, offset by soft revenues.
Shares of Mednax (NYSE:MD) were flat in pre-market trading after the company reported Q2 results.
Mednax (MD) delivered earnings and revenue surprises of 113.33% and -13.83%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX Reports Second Quarter Results Results from Continuing Operations Reflect Significant Recovery in Second Half of Quarter Following Initial Disr
Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX 2020 Second Quarter Conference Call/Webcast Scheduled for Thursday, July 30, 2020
Pressure from the COVID-19 impact on global economy and lack of solvency make MEDNAX (MD) an unattractive bet.
MEDNAX (MD) declares several transformational activities, which augur well for the long term.
Mednax (MD) reported earnings 30 days ago. What's next for the stock?
Even though MEDNAX (MD) endures the COVID-19 impact on global economy, it holds prospects to revive its fortunes with the help of its initiatives and strong fundamentals.
MEDNAX's (MD) affiliate Jefferson Radiology collaborates with CDI for providing enhanced healthcare services to the Springfield community.
MEDNAX (MD) sells its American Anesthesiology to NAPA for portfolio rationalization and averting the negative COVID-19 impact.
MEDNAX, Inc. (MD) CEO Roger Medel on Q1 2020 Results - Earnings Call Transcript
MEDNAX's (MD) Q1 results reflect the coronavirus adversities that drained its revenues and volumes.
Shares of Mednax (NYSE:MD) fell 10% after the company reported Q1 results. Quarterly Results Earnings per share fell 50.77% over the past year to $0.32, which missed the estimate of $0.56.
Mednax (MD) delivered earnings and revenue surprises of -23.81% and 1.29%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Even though MEDNAX (MD) endures the COVID-19 impact on global economy, it holds high prospects to revive its fortunes by virtue of its solid fundamentals.
MEDNAX (MD) takes several steps to help fight the COVID-19 pandemic.
MEDNAX (MD) takes back its first-quarter 2020 and preliminary full-year outlook due to the COVID-19 effect.
About MD
MEDNAX, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant moth... [Read more...]
| Industry Medical Care Facilities | IPO Date Sep 19, 1995 |
| Stock Exchange NYSE | Ticker Symbol MD |
Financial Performance
In 2020, MEDNAX, Inc.'s revenue was $1.73 billion, a decrease of -2.57% compared to the previous year's $1.78 billion. Losses were -$796.49 million, -46.82% less than in 2019.
Analyst Forecasts
According to 11 analysts, the average rating for MEDNAX, Inc. stock is "Hold." The 12-month stock price forecast is 20.35, which is a decrease of -16.70% from the latest price.